Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Antimicrobial Resistance of Helicobacter pylori Isolated from Korean Children

한국인 소아에서 분리한 Helicobacter pylori 균주의 항균제 내성률

  • Kim, Yoo-Mi (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Lee, Yeoun-Joo (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Oh, Seak-Hee (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Sung, Heung-Sup (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Mi-Na (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Kyung-Mo (Department of Pediatrics, Asan Medical Center Children's Hospital)
  • 김유미 (울산대학교 의과대학 서울아산소아청소년병원 소아청소년과) ;
  • 이연주 (울산대학교 의과대학 서울아산소아청소년병원 소아청소년과) ;
  • 오석희 (울산대학교 의과대학 서울아산소아청소년병원 소아청소년과) ;
  • 성흥섭 (서울아산병원 진단검사의학과) ;
  • 김미나 (서울아산병원 진단검사의학과) ;
  • 김경모 (울산대학교 의과대학 서울아산소아청소년병원 소아청소년과)
  • Received : 2010.08.13
  • Accepted : 2010.09.08
  • Published : 2011.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The antimicrobial resistance of Helicobacter pylori is one of the critical factors in failure of eradication therapy. The purpose of this study was to evaluate antimicrobial resistance of H. pylori in Korean children. Methods: Gastric mucosal specimens for H. pylori were obtained from children with dyspepsia who were cared for at Asan Medical Center Children's Hospital in Seoul, Korea between 2003 and 2009. Antimicrobial resistance tests were performed using the disk diffusion method for clarithromycin and amoxicillin and the E-test for metronidazole and tetracycline. Most children with H. pylori infections were treated using triple therapies. Results: Thirty-three children had positive H. pylori cultures, although a resistance test was only performed in 28 patients. Resistant strains were found in 9 children (32.1%). The resistance rates to clarithromycin and metronidazole were 25% and 17.8%, respectively. There was no resistance to amoxicillin or tetracycline. The resistance rates decreased from 44.4% (2003~2006) to 26.3% (2006~2009) during the study period. Conclusion: Korean children demonstrated relatively high antimicrobial resistance to H. pylori in this study. However, there was a temporarily decreasing trend during the study period. A larger multi-regional study may be needed to determine the optimal antimicrobial treatment for pediatric patients infected with H. pylori.

목 적: Helicobacter pylori (H. pylori) 제균 치료의 적절한 항균제 선택의 기반이 되기 위해 소아에서 H. pylori 항균제 내성률을 알아보고자 하였다. 방 법: 2003년 7월부터 2009년 4월까지 상복부 통증으로 본원을 방문한 환자 중 위 문부 생검 조직 배양에서 H. pylori 가 동정된 균주를 대상으로 항균제 감수성 검사를 시행하였다. 감수성 검사는 clarithromycin과 amoxicillin은 디스크 확산법으로, tetracycline과 metronidazole은 E-test를 시행하였다. 치료 원칙은 감수성 결과가 확인 된 환자는 감수성 결과에 따라 항균제를 선택 하였고, BAM (bismuth subsalicylate, amoxicillin, metronidazole) 또는 OAC (omeprazole, amoxicillin, clarithromycin)를 바탕으로 한 경험적 삼제요법을 택하였다. 치료 실패 시에는 bismuth (또는 bismuth subsalicylate)를 포함한 사제요법을 선택하였다. 결 과: 33명의 환자가 배양검사 양성을 보였고 28명의 환자에서 감수성 검사를 시행하였다. 이 중 항균제 내성을 보인 환아는 9명(32.1%)으로 그 중 7명(25%)이 clarithromycin 내성 균주를 보였고 5명(17.8%)이 metronidazole 내성 균주를 보였다. 대상이 적어 통계적인 분석을 하지 못하였으나 Clarithromycin과 metronidazole의 내성률이 시기적으로 감소하는 추세를 보였다. 결 론: 본 연구는 단일 병원에서 소수의 환아를 대상으로 이루어진 연구로 한계가 있으나, 간접적으로 국내소아 환아에서 분리된 H. pylori의 균주에서도 높은 항균제 내성과 시기적으로 내성률이 변하는 것을 알 수있었다. 따라서 소아 환자에서 적절한 항균제 선택을 제시하기 위한 보다 광범위한 연구가 필요한 것으로 생각한다.

Keywords

References

  1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-9. https://doi.org/10.1001/jama.1994.03520010077036
  2. Dohil R, Hassall E, Jevon G, Dimmick J. Gastritis and gastropathy of childhood. J Pediatr Gastroenterol Nutr 1999;29:378-94. https://doi.org/10.1097/00005176-199910000-00004
  3. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59. https://doi.org/10.1093/oxfordjournals.epirev.a036078
  4. Gottrand F, Turck D, Vincent P. Helicobacter pylori infection in early infancy. Lancet 1992;340:495.
  5. Rhee HS, Kim HS, Jang JJ, Seo JK. Endoscopic and pathologic analysis of pediatric Helicobacter pylori gastritis. Korean J of Gastroenterol 2000;36:10-9.
  6. Drumm B, Sherman P, Cutz E, Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987;316:1557-61. https://doi.org/10.1056/NEJM198706183162501
  7. Mitchell HM, Bohane TD, Tobias V, Bullpitt P, Daskalopoulos G, Carrick J, et al. Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastrenterol Nutr 1993;16:120-5. https://doi.org/10.1097/00005176-199302000-00004
  8. Gottrand F, Cullu F, Turck D, Vincent P, Michaud L, Husson MO, et al. Normal gastric histology in Helicobacter pylori-infected children. J Pediatr Gastroenterol Nutr 1997;25:74-8. https://doi.org/10.1097/00005176-199707000-00012
  9. Langenberg W, Rauws EA, Houthoff HJ, Oudbier JH, van Bohemen CG, Tytgat GN, et al. Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis 1988;157:1245-9. https://doi.org/10.1093/infdis/157.6.1245
  10. Choe YH. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. Korean J Pediatr 2004;47:235-9.
  11. Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7. https://doi.org/10.1097/00005176-200011000-00007
  12. Kim KM, Oh YL, Ko JS, Choe YH, Seo JK. Histopathology and expression of Ki-67 and cyclooxygenase- 2 in childhood Helicobacter pylori gastritis. J Gastroenterol 2004;39:231-7. https://doi.org/10.1007/s00535-003-1282-9
  13. Sung HS, Chung HJ, Kim MN, Lee GH. Clinical usefulness of antimicrobial susceptibility test for Helicobacter pylori. Korean J Lab Med 2006;26:179-84. https://doi.org/10.3343/kjlm.2006.26.3.179
  14. Sung HS, Kang JO, Lee MA, Lee JW, Lee HK, Lee MK, et al. Clarithromycin and amoxicillin susceptibility testing of Helicobacter pylori by disk diffusion method. Korean J Clin Microbiol 2009;12:30-6. https://doi.org/10.5145/KJCM.2009.12.1.30
  15. Malfertheiner P, Me' graud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
  16. Kim JG. Treatment of Helicobacter pylori infection. Korean J Gastroenterol 2005;46:172-80.
  17. Lee JH, Kim HY, Park JK, Sim JH, Kim JW, Hwang JH, et al. Current effectiveness of Helicobacter pylori eradication treatment in primary care setting in Korea. Korean J Med 2003;65:422-5.
  18. Murakami K, Nasu M. Drug sensitivity test for Helicobacter pylori. Nippon Rinsho 2002;60(Suppl 2):350-3.
  19. Osato MS. Antimicrobial susceptibility testing for Helicobacter pylori: sensitivity test results and their clinical relevance. Curr Pharm Des 2000;6:1545-5. https://doi.org/10.2174/1381612003399059
  20. Smaill F. Antibiotic susceptibility and resistance testing: an overview. Can J Gastroenterol 2000;14:871-5. https://doi.org/10.1155/2000/382415
  21. Kato S, Fujimura S, Udagawa H, Shimizu T, Maisawa S, Ozawa K, et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002; 40:649-53. https://doi.org/10.1128/JCM.40.2.649-653.2002
  22. National Committee for Clinical Laboratory Standard. Perfomance standards for antimicrobial susceptibility testing: informational supplement. NCCLS document M100-S9. Wayne (PA): NCCLS, 1999.
  23. Kim ES, Kang JO, Han DS, Park PW, Par IK, Choi TY. Comparison of modified broth microdilution method, E test, and disk diffusion method for antimicrobial susceptibility testing of Helicobacter pylori. Korean J Clin Pathol 1998;18:559-64.
  24. Kang JO, Han DS, Choi TY. Evaluation of four methods for antimicrobial susceptibility testing of Helicobacter pylori in routine practice. Korean J Clin Microbiol 2005;8:82-9.
  25. Chung CH, Kim JJ, Kim YH, Rhee PL, Rhee JC, Graham DY, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. Korean J Helicobacter Res Prac 2002;2:57-60.
  26. Lee H, Kim JJ. Impact of metronidazole resistance on eradication rate for Helicobacter pylori. Korean J Gastroenterol 2005;46:142-5.
  27. Lee HK, Chae HS, Kang JO, Lee MK, Sung HS, Kim MN, et al. Multicenter study for the frequency of 23S rRNA point mutations associated with clarithromycin resistance in Helicobacter pylori in Korea. Korean J Clin Microbiol 2008;11:84-9. https://doi.org/10.5145/KJCM.2008.11.2.84
  28. Kim JM. Antibiotics resistance of Helicobacter pylori isolated from Korean patients. Korean J Gastroenterol 2006;47:337-49.
  29. Chung WC, Lee KM, Paik CN, Lee JR, Jung SH, Kim JD, et al. Inter-departmental differences in the eradication therapy for Helicobacter pylori infection: a single center study. Korean J Gastroenterol 2009;53:221-7.
  30. Kim SJ, Kim JG, Jung K, Hong YH, Kim JH, Jung HR, et al. Antimicrobial resistance rate of Helicobacter pylori isolates and detection of mechanism of clarithromycin resistance. Korean J Med 2001;61:470-8.
  31. Bang SY, Han DS, Eun CS, Kim JE, Ahn SB, Sohn JH, et al. Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease. Korean J Gastroenterol 2007;50:356-62.
  32. Agudo S, Alarcón T, Cibrelus L, Urruzuno P, Martínez MJ, López-Brea M. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev Esp Quimioter 2009;22:88-92.
  33. Wewer V, Kalach N. Helicobacter pylori infection in pediatrics. Helicobacter 2003:8(Suppl 1):61-7. https://doi.org/10.1046/j.1523-5378.2003.00165.x

Cited by

  1. Organic Upper Digestive Diseases in Children with Chronic Abdominal Pain vol.14, pp.3, 2011, https://doi.org/10.5223/kjpgn.2011.14.3.232